SG11201707117SA - Ophthalmic composition - Google Patents
Ophthalmic compositionInfo
- Publication number
- SG11201707117SA SG11201707117SA SG11201707117SA SG11201707117SA SG11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA
- Authority
- SG
- Singapore
- Prior art keywords
- ophthalmic composition
- ophthalmic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015045065 | 2015-03-06 | ||
| PCT/JP2016/056861 WO2016143708A1 (en) | 2015-03-06 | 2016-03-04 | Ophthalmic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201707117SA true SG11201707117SA (en) | 2017-10-30 |
Family
ID=56880167
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201901426WA SG10201901426WA (en) | 2015-03-06 | 2016-03-04 | Ophthalmic composition |
| SG11201707117SA SG11201707117SA (en) | 2015-03-06 | 2016-03-04 | Ophthalmic composition |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201901426WA SG10201901426WA (en) | 2015-03-06 | 2016-03-04 | Ophthalmic composition |
Country Status (7)
| Country | Link |
|---|---|
| JP (2) | JP6716293B2 (en) |
| KR (1) | KR102607126B1 (en) |
| MY (1) | MY190393A (en) |
| PH (1) | PH12017501567B1 (en) |
| SG (2) | SG10201901426WA (en) |
| TW (2) | TWI745287B (en) |
| WO (1) | WO2016143708A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3871682A1 (en) * | 2016-10-14 | 2021-09-01 | i.com Medical GmbH | Method for establishing, restoring, and preserving homeostasis of the ocular surface |
| JP6603785B2 (en) * | 2017-12-08 | 2019-11-06 | 千寿製薬株式会社 | Aqueous solution containing water-soluble polymer |
| CN114845734A (en) * | 2019-12-27 | 2022-08-02 | 乐敦制药株式会社 | Aqueous composition |
| CN112870216A (en) * | 2021-01-29 | 2021-06-01 | 张宽才 | Pharmaceutical composition, preparation and application |
| JP7770800B2 (en) * | 2021-08-03 | 2025-11-17 | 小林製薬株式会社 | Eyewash composition |
| CN114391550B (en) * | 2022-01-06 | 2022-11-22 | 江南大学 | Water-soluble chlorhexidine antibacterial agent and preparation method and application thereof |
| WO2024135344A1 (en) * | 2022-12-21 | 2024-06-27 | ライオン株式会社 | Ophthalmic product |
| KR20250009371A (en) | 2023-07-10 | 2025-01-17 | 주식회사 대웅테라퓨틱스 | Pharmaceutical composition comprising diquafosol having improved stability |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1072376A (en) * | 1996-09-02 | 1998-03-17 | Ofutekusu:Kk | Eye drop aqueous solution comprising hyaluronic acid |
| JPH1160505A (en) * | 1997-05-20 | 1999-03-02 | Senju Pharmaceut Co Ltd | Antiseptic composition |
| JPH115744A (en) * | 1997-06-16 | 1999-01-12 | Toa Yakuhin Kk | Aqueous solution preparation for external use containing hyaluronic acid |
| JP2002193815A (en) * | 2000-12-25 | 2002-07-10 | Ophtecs Corp | Eye drops for prevention of corneal drying for ophthalmic operation |
| JP2003002837A (en) * | 2001-06-21 | 2003-01-08 | Lion Corp | Aqueous external preparation composition and method for preventing clouding of liquid composition |
| JP4431817B2 (en) | 2002-03-08 | 2010-03-17 | 第一三共株式会社 | Eye drops containing tetrazole derivatives |
| JP4694773B2 (en) * | 2003-06-06 | 2011-06-08 | ロート製薬株式会社 | Mucosal liquid composition |
| EP1781305A2 (en) * | 2004-08-13 | 2007-05-09 | Angiotech International Ag | Compositions and methods using hyaluronic acid and hyaluronidase inhibitors |
| EP2090314A4 (en) | 2006-10-26 | 2010-01-13 | Senju Pharma Co | AQUATIC OPHTHALMIC LIQUID PREPARATION |
| JP5595206B2 (en) * | 2009-09-30 | 2014-09-24 | ロート製薬株式会社 | Ophthalmic liquid composition |
| PH12013502476B1 (en) * | 2011-06-23 | 2019-04-17 | Santen Pharmaceutical Co Ltd | Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol |
-
2016
- 2016-03-04 TW TW105106856A patent/TWI745287B/en active
- 2016-03-04 WO PCT/JP2016/056861 patent/WO2016143708A1/en not_active Ceased
- 2016-03-04 TW TW109144686A patent/TW202114648A/en unknown
- 2016-03-04 JP JP2016042598A patent/JP6716293B2/en active Active
- 2016-03-04 MY MYPI2017001274A patent/MY190393A/en unknown
- 2016-03-04 KR KR1020177026380A patent/KR102607126B1/en active Active
- 2016-03-04 SG SG10201901426WA patent/SG10201901426WA/en unknown
- 2016-03-04 SG SG11201707117SA patent/SG11201707117SA/en unknown
- 2016-03-04 PH PH1/2017/501567A patent/PH12017501567B1/en unknown
-
2020
- 2020-06-10 JP JP2020100802A patent/JP2020138979A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PH12017501567A1 (en) | 2018-02-05 |
| TW202114648A (en) | 2021-04-16 |
| KR102607126B1 (en) | 2023-11-27 |
| WO2016143708A1 (en) | 2016-09-15 |
| SG10201901426WA (en) | 2019-03-28 |
| KR20170122773A (en) | 2017-11-06 |
| JP6716293B2 (en) | 2020-07-01 |
| JP2020138979A (en) | 2020-09-03 |
| MY190393A (en) | 2022-04-20 |
| TW201705948A (en) | 2017-02-16 |
| TWI745287B (en) | 2021-11-11 |
| PH12017501567B1 (en) | 2022-11-23 |
| JP2016166195A (en) | 2016-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201707617VA (en) | Ophthalmic composition | |
| GB201512030D0 (en) | Composition | |
| GB201505527D0 (en) | Composition | |
| PL3373973T3 (en) | Ocular compositions | |
| GB201506827D0 (en) | Composition | |
| ES2924645T5 (en) | Ophthalmic suspension composition | |
| GB201619525D0 (en) | Ophthalmic composition | |
| SG11201707117SA (en) | Ophthalmic composition | |
| GB201506829D0 (en) | Composition | |
| GB201506830D0 (en) | Composition | |
| GB201506825D0 (en) | Composition | |
| GB201504665D0 (en) | Composition | |
| GB201504307D0 (en) | Composition | |
| GB201506828D0 (en) | Composition | |
| GB201505520D0 (en) | Composition | |
| GB201511697D0 (en) | Composition | |
| GB201509044D0 (en) | Composition | |
| PL3446682T3 (en) | Ophthalmic composition | |
| GB201508722D0 (en) | Composition | |
| GB201506826D0 (en) | Composition | |
| ZA201703701B (en) | Ophthalmic composition | |
| IL251590B (en) | Ophthalmic compositions | |
| GB201509641D0 (en) | Composition | |
| PT3470059T (en) | Ophthalmic suspension composition | |
| GB201506765D0 (en) | Composition |